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Staphylococcus aureus is a major human pathogen that is well known for its
ability to develop resistance to antimicrobial therapies. Recent studies have identified a
combination of β-lactam antibiotic and daptomycin (DAP) to be highly effective at
killing single and multi-drug-resistant S. aureus. Of particular interest is this drug
combination’s efficiency with which it kills strains classified as DAP-resistant
methicillin-resistant Staphylococcus aureus (DAP-R MRSA). The goals of the present
study were two-fold: to provide a physiological profile of a DAP-R S. aureus strain
undergoing beta-lactam treatment by observing changes in autolytic rate, susceptibility to
lytic enzymes, levels of peptidoglycan O-acetylation, release of lipoteichoic acid, and
localization of the major cellular autolysin Atl. Additionally, the manner by which βlactam+DAP therapy was bactericidal was explored by examining cell viability and
culture optical density in response to DAP+Nafcillin (NAF). The strains used in this
study were a well-characterized DAP-R MRSA D712 and its isogenic DAP-Susceptible
MRSA precursor (DAP-S MRSA) D592. Growth of DAP-S and DAP-R MRSA in the
presence of the nafcillin increased whole cell and crude cell wall (CCW) autolysis.

Interestingly, while D712 initially exhibited decreased whole cell autolysis both strains
responded remarkably similarly to triton X-100 stimulated autolysis. CCWs of both
D592 and D712 were almost entirely resistant to autolysis, lysing only ~10% over four
hours. After NAF treatment a significant increase in autolysis was observed, however,
the increase was more pronounced in D592. NAF exposure also increased purified cell
wall (PCW) susceptibility lysoszyme and lysostaphin. Similar to CCW autolysis, nearly
complete resistance to lysozyme was reversed upon growth in NAF, in contrast,
lysostaphin was effective at lysing PCW, and NAF exposure produces a pronounced
effect. Interestingly, D712 exhibited slight lysostaphin resistance, a phenotype that may
be worth investigating. Despite the dramatic increase in lysoszyme susceptibility, growth
in NAF did not result in attenuation in the level of O-acetyl groups, a factor that has been
previously implicated in lysozyme resistance. In addition, NAF exposure appeared to
alter Atl processing. Cell wall protein extracts in equal amounts displayed a highly
similar ability to lyse suspended Micrococcus luteus cells, providing evidence that Atl
may be delocalized upon NAF treatment. Together, these data suggest that changes in
cell wall structure caused by β-lactams that may render cells more susceptible to
daptomycin, and elucidation of these factors provided clues to the complicated nature of
DAP resistance and will guide future research.
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CHAPTER I
INTRODUCTION
Since the introduction of penicillin in the early part of the twentieth century
antibiotics have revolutionized the medical world, enabling practitioners to treat
previously fatal infections with compounds that are relatively harmless to the patient.
However, a significant problem with antibiotic therapy is the emergence of resistance to a
particular compound within the organism being treated. The gram-positive pathogen
Staphylococcus aureus is known to rapidly evolve resistance to novel antibiotics: in
1960-only one to two years after the introduction of methicillin--a penicillinase-resistant
member of the β-lactam antibiotic family, methicillin-resistant Staphylococcus aureus
(MRSA) strains began to emerge (1).
Today, MRSA infections number approximately 75,000 annually (2). Treatment
for MRSA bacteremia and infective endocarditis typically consists of antimicrobial
monotherapy with vancomycin (VAN) or daptomycin (DAP) (3). Treatment with VAN
or DAP as first and second line treatments can in many cases lead to the emergence of
resistance phenotypes (4), leaving practitioners with limited therapeutic options. The
emergence of resistance phenotypes is a common and expected phenomenon. Traditional
practice when treating resistant infections has been to change therapy to an antibiotic to
which the organism remains susceptible; however, this inevitably leads to resistance
evolving to the novel compound. Continued use ultimately leads to a dwindling arsenal of
new antimicrobials with which to treat infections. One strategy to combat the emergence
1

of drug resistance is to develop combination therapies that utilize currently available
compounds to more effectively treat drug resistant infections. Although there is currently
no approved combination therapy for the treatment of MRSA bacteremia it has been
shown in a number of cases that a combination of an antistaphylococcal β-lactam and
DAP is an extremely effective combination (4), having cleared infections that had
persisted for up to three weeks surviving and developing resistance to vancomycin and
daptomycin monotherapy (5). Although the effectiveness of the β-lactam+DAP
combination therapy is interesting in its own right it is especially fascinating that
daptomycin resistant (DAP-R) strains exhibited a daptomycin susceptible (DAP-S)
phenotype when challenged with this drug combination (4).
β-lactam Antibiotics
Penicillin, the most well known of the β-lactams, was discovered by Alexander
Fleming in 1928. Following this discovery was a torrent of research that determined that
strain, media, and culture conditions resulted in several penicillin derivatives (6),
However, the presence of a characteristic “β-lactam” ring remained constant, hence the
drug class name. Despite the initial efficacy of penicillin, resistant strains of S. aureus
developed quickly, and within twenty years more than 80% of strains were found to be
penicillin-resistant (7). In response to increasing prevalence of penicillin-resistant
strains, considerable work was put into developing penicillin derivatives that would
remain effective. One highly successful derivative is methicillin, the first penicillinaseresistant β-lactam which was approved for clinical use in the United States in 1960 (6, 7).
Synthesis of β-lactam derivatives has proven invaluable in modern medicine, however,
natural product discovery has led to the development of compounds with notably
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different β-lactam rings. For example, cephalosporins possess an entirely different “βlactam nucleus” to that of penicillin (6-APA vs. 7-ACA, respectively), while
carbapenems and monobactams are significantly different from both penicillin’s 6-APA
ring and the cephalosporin 7-ACA ring (6).
β-lactam resistance can develop in several ways. Penicillin resistance is rooted in
the secretion of penicillinase, an enzyme that breaks down penicillin. To combat
penicillinase-based resistance, methicillin, a penicillinase-resistant β-lactam was
introduced. Despite methicillin’s initial effectiveness resistant strains were quickly
found, some as early as the year of its clinical approval (1, 6, 7). Although β-lactamases
are an effective mechanism of resistance, they are not the only mechanism. Other critical
sources of β-lactam resistance lie in the penicillin-binding proteins (PBPs), the binding
target of β-lactams that are integral in the construction of the cell wall. S. aureus
typically encodes four PBPs (PBP1-4). Methicillin resistance is rooted in the acquisition
of Staphylococcal Chromosomal Cassette mec (SCCmec) which includes the mecA gene
that encodes a fifth PBP, PBP2a—a PBP with low affinity for β-lactams allowing
unperturbed cell wall synthesis in the presence of β-lactams (7). Although the presence
of PBP2a is pivotal in the development of β-lactam resistance, previous work has
reinforced the important roles of other PBPs in the context of alternative therapies,
demonstrating that β-lactams that selectively target PBP1 enhance DAP activity to a
greater extent than those that non-selectively inhibit PBPs such as nafcillin (8).
Daptomycin
Daptomycin is a 1.6 kDa anionic lipopeptide antibiotic that associates with Ca2+
in its active form giving it a net positive charge. It is isolated from Streptomyces
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roseosporus and was approved for clinical use in 2004 (9, 10). Current models for the
DAP mechanism of action identifies the target of DAP as the cell membrane, where it
binds phospatidylglycerol and aggregates, causing the leakage of ions, membrane
depolarization, disruption of protein, DNA and RNA synthesis and ultimately cell death
(9, 11). To bind its target, DAP requires Ca2+, the binding of which results in
conformational changes that account for membrane insertion and oligomerization
potentially as a result of increased exposure of hydrophobic residues in the molecule (9).
Daptomycin resistance is complex, involving a diverse range of genes ranging from those
responsible for membrane lipid biosynthesis to cell wall regulation (12, 13).
Interestingly, gain of function mutations in the gene mprF – responsible for synthesis of
lysyl phosphatidylglycerol, a positively charged membrane phospholipid –have been
found to be relatively common in clinical DAP-R isolates (14). Due to the increased
presence of positively charged phospholipids in clinical DAP-R strains a charge repulsion
mechanism has been proposed as part of the DAP resistance phenotype, while for in vitro
derived strains charge repulsion cannot always explain resistance (14). Previous work
has demonstrated that exposure to β-lactams results in increased DAP binding (4)
suggesting that a decrease in cell surface positive charge is associated with β-lactam
treatment. It is speculated that release of membrane-bound lipoteichoic acid (LTA),
which is often modified with D-alanine, thereby increasing the overall net positive charge
of the membrane, could play a role in the increased ability of DAP to bind its target. This
is supported by research demonstrating the exceptionally increased binding ability of
mammalian group IIa phosphpolipases A2, which are similarly charged and bind similar
targets as DAP, to S. aureus strains with mutations in dltA, rendering them unable to add
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D-alanine to LTA (15). Exposure to β-lactam antibiotics has been shown to cause the
release of LTA from the cell membrane (16); however, this has yet to be directly
demonstrated in a study examining this synergy. Further evidence for the significance of
charge-based repulsion has been provided by Sakoulas et. al. (5), where enhanced
binding and killing due to host cationic defense peptides was observed upon treatment
with sub-MIC concentrations of the β-lactam nafcillin (NAF).
Unlike β-lactam antibiotics that primarily cause cell lysis due to a weakened cell
wall, DAP can be bactericidal without lysis (17). When challenged with daptomycin,
early exponential phase cells exhibit rapid loss of viability with little to no concomitant
drop in optical density, implying a lack of lysis, which was further confirmed by electron
microscopy (17). Interestingly, previous work has demonstrated an ability of daptomycin
to remain lethal against stationary-phase cultures. Although daptomycin does affect cell
division machinery, and thus the cell wall (12, 17, 18), it remains to be determined
whether cells undergoing β-lactam+DAP therapy are preferentially killed by one
antimicrobial mechanism or another.
Autolysins
Previous work has demonstrated that growth of MRSA in β-lactam-containing
media causes whole cells to exhibit increased autolysis, and crude and purified cell wall
preparations are more susceptible to degradation by lysozyme (17). One potential source
of increased autolysis could be a result of delocalization of the major cellular autolysin
Atl. In addition to charge-based repulsion, simple size exclusion is another potential
source of DAP resistance. Previous studies of vancomycin-resistant strains have found
that VAN resistance and DAP resistance are correlated with increased cell wall thickness
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(10). It could be possible that delocalized Atl sufficiently weakens the cell wall and
“opens” it to penetration by DAP molecules.
Autolysins, named for their capacity to cause rapid cell lysis unless tightly
regulated are also commonly referred to as peptidoglycan hydrolases and play significant
roles in the regulation of cell wall growth/turnover and the separation of daughter cells
during cell division (19, 20). AtlA is the most prominent peptidoglycan hydrolase in S.
aureus with implications in cell wall maintenance and cell division as well the initial
stages of biofilm formation (19, 20). AtlA is expressed as a 137.5 kDa pro-protein that is
cleaved into four distinct parts, two of which are amidase and glucosaminidase domains
that are responsible for much of the previously discussed function of Atl (20). Loss of
the atl gene has been shown to decrease the effectiveness of lytic antimicrobials such as
β-lactams, due to the cell’s inability to divide (21). In addition to Atl, Sle1 is another
important hydrolase involved in cell septation, although it has not been determined to be
implicated in autolysis of S. aureus (22).
In addition to autolysins, several antibacterial lytic enzymes are classified as
peptidoglycan hydrolases, two of these enzymes are lysozyme and lysostaphin.
Lysozyme is an antimicrobial enzyme naturally produced by many organisms, and one of
the most common sources of lysozyme is hen egg white (7). Lysozyme targets the bond
joining the N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) subunits of
peptidoglycan (PGN) to cause rapid lysis, although many pathogenic organisms, S.
aureus included, are highly resistant to lysozyme. Currently, the O-acetylation of C-6 on
NAM is proposed as the reason for this resistance, since many non-pathogenic organisms
(Staphyococcus carnosus and Staphyococcus xylosus for example) lack O-acetyl groups
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(23, 24). Lysostaphin is a potent lytic enzyme that is isolated from Staphylococcus
simulans biovar staphylolyticus, and is effective against most species due to its targeting
of the staphylococcal-specific pentaglycine cross-bridge that cross-links individual
strands of PGN (7, 25, 26).
Lipoteichoic Acid
The staphylococcal cell envelope consists primarily of PGN and teichoic acids
(TAs) (27). While PGN is well characterized, the functions of teichoic acids are not fully
known (27). Teichoic acids are of two types: wall teichoic acids (WTA) and lipoteichoic
acids (LTA), and determining the specific function of each has been made complicated
due to their multiple functions, several of which overlap (27). LTA are embedded in the
cell membrane and composed of a polyglycerolphosphate backbone, while WTA are
covalently linked to cell wall PGN and composed of a polyribitolphosphate backbone
(24, 27). An important modification to teichoic acids is D-alanylation, which occurs via
proteins specified by the dlt operon. D-alanine serves a general function as a counterion
to determine net anionic charge of a teichoic acid (24). The dlt operon consists of four
genes (dltABCD) that slightly overlap (24). dltA and dltC encode Dcl and Dcp,
respectively, while dltB encodes a transport protein and dltD a membrane protein.
Together, the general model of LTA D-alanylation consists of attachment of D-alanine to
Dcp by Dcl and transport to the extracellular surface through a channel (DltB), with DltD
serving as a binding site for both Dcp and Dcl (24). Interestingly, it has been determined
that D-alanine esters on WTA are derived from LTA, however, the process by which this
happens is not clear (24).

7

In B. subtilis, inactivation of dltABC or D results in both wall and lipoteichoic
acids lacking D-alanine; additionally, strains deficient in D-alanine exhibited increased
autolysis and methicillin sensitivity (24). S. aureus dlt mutants are unable to alanylate
their teichoic acids and exhibit increased susceptibility to cationic host defense peptides
due to the increased net anionic charge on TAs (24). D-alanyl TAs have had a multitude
of functions ascribed to them depending on the species. These functions include general
cation homeostasis, cell wall electrochemical composition, protein folding, antibiotic
resistance, and biofilm formation (24). As previously mentioned, D-alanine can migrate
between LTA and WTA with relative ease, and it has been proposed that the location of
D-alanine may serve as a signal for proteins that require specific ionic environments to
function (24). One class of proteins that fit this description are autolysins, thus, a loss of
LTA leads to hypo-alanylated WTA, which could lead to autolysin delocalization.
Specific Aims and Hypotheses
Cell wall physiology and autolytic properties are essential knowledge when
understanding mechanisms of resistance and DAP-R cells are relatively uncharacterized
in the context of β-lactam+DAP therapy. To remedy this, we aimed to document the
physiological changes in the bacterial cell wall and cell wall-associated elements pre- and
post-β-lactam treatment. We hypothesized that growth in media containing NAF would
result in a wide range of effects including increased rates of autolysis of whole cells and
crude cell walls in addition to cells with walls with a decreased level of O-acetylation that
are more prone to lysis by lytic enzymes. In addition, we expected to see increased
liberation of LTA into the culture medium, a phenomenon that may be implicated in
increased autolysis due to delocalization of the major cellular autolysin Atl.
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Our second objective was to examine the loss of cell viability in response to βlactam+DAP treatment. We expected that exponentially growing cells would exhibit cell
lysis as the main mode of killing during β-lactam+DAP therapy, likely due to the
compounding physiological defects in the cell wall induced by β-lactams as well as
daptomycin. We expected that this combination would not remain effective against
stationary-phase cells, despite DAP’s potential to kill stationary-phase cells by
depolarizing the membrane and disrupting protein, DNA, and RNA synthesis due to an
inability to reach and/or bind its target at the cell membrane.
Determination of the cell wall physiological properties of DAP-R cells in
response to beta-lactam treatment as well as clarification of the mode of killing during the
course of β-lactam+DAP therapy is crucial to further elucidation of the mechanism of
DAP resistance, and may prove useful for the development of future therapies for the
treatment of DAP-R isolates.
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CHAPTER II
MATERIALS AND METHODS
The strains of S. aureus utilized in this study are D712, a daptomycin-resistant,
methicillin-resistant, vancomycin-intermediate Staphylococcus aureus (DAP-R VISA)
and D592, its daptomycin-susceptible, methicillin-resistant, heterogeneously
vancomycin-intermediate (DAP-S hVISA) isogenic precursor. Both strains were
provided by Dr. George Sakoulas (University of California, San Diego). Experiments
were performed in triplicate and averaged unless stated otherwise. Statistical significance
of lysis assays was determined by Kolmogorov-Smirnov (K-S) test while bar charts were
subjected to t-test. All calculations were performed in Microsoft Excel.
Whole Cell Autolysis Assays
Overnight cultures of S. aureus D592 and D712 were prepared in Tryptic Soy
Broth (TSB) and then diluted 1:50 into TSB or TSB containing 20 µg/ml NAF and grown
to mid-exponential phase (OD600 0.6-0.7). Cells were then harvested by centrifugation
(10 minutes, 13,000 xg) at 4°C. Following two washes with cold dH2O cell pellets were
resuspended to OD600 0.5-0.7 in pH 7.5 lysis buffer containing 0.05 M Tris-HCl and
0.05% wt/vol Triton X-100. Cells were then incubated in spectrophotometer cuvettes at
37°C for four hours, and the OD600 was observed every thirty minutes. Data are presented
as a percentage of initial OD.
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Isolation of Crude and Purified Cell Wall Fragments
Isolation of cell walls was carried out essentially the same as Bera et. al (24) with
some modifications. Overnight cultures of S. aureus D592 and D712 were prepared in
TSB and then diluted 1:50 into plain fresh TSB or fresh TSB containing 20 µg/ml NAF
and grown to mid-exponential phase (OD600 0.6-0.7) at 37°C with 200 RPM shaking.
Cells were then harvested by centrifugation at 4°C for 10 minutes at 13,000 xg and
washed twice in an excess cold 0.9% NaCl for 10 minutes. Following washing, pellets
were resuspended in cold 0.9% NaCl and mechanically disrupted using 0.1mm glass
beads in five two minute intervals for a total of ten minutes of disruption. Glass beads
were separated from disrupted cell material by vacuum filtration through a 40µm filter,
and the cell fragments transferred to centrifuge tubes for harvesting (as done previously).
After harvesting, a portion of the crude cell wall fraction (CCW) was resuspended in cold
dH2O and saved for use in CCW autolysis experiments. The remaining material was
washed twice in cold dH2O before boiling in 2% SDS for 30 minutes. After boiling in
SDS, peptidoglycan was harvested by centrifugation at 20°C and then washed twice in
room temperature dH2O. After washing, remaining material was incubated overnight at
37°C in 0.1M Tris-HCl solution (pH 6.8) containing 100 µg/ml Proteinase K. Following
proteinase K treatment the solution was harvested by centrifugation for 10 minutes at
13,000 xg, washed four times in room temperature dH2O to remove as much left over
SDS as possible, and then lyophilized and saved as purified cell wall (PCW) fragments.
CCW Autolysis
CCWs obtained from mechanical disruption using glass beads were diluted in
0.05M K2HPO4 buffer pH 7.2 to OD580 0.4-0.6, incubated at 37°C for four hours and the
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OD580 was monitored every thirty minutes. Data are presented as a percentage of the
initial OD.
PCW Lysis
Lyophilized PCWs were resuspended in Tris-HCl pH 7.5 to OD580 0.5-0.6 and
incubated with 100 µg/ml lysozyme at 37°C for four hours and the OD580 was monitored
every thirty minutes. A lysostaphin lysis assay was carried out alongside the lysozyme
assay with a few modifications: a concentration of 5 µg/ml lysostaphin was used, and
OD620 was monitored instead of OD580 in accordance with established lysostaphin lysis
assay protocols (25). Data are presented as a percentage of the initial OD.
Degree of O-acetylation
Taking care to keep pH below 7.0 during the isolation of PCW ensures that the
highly alkali-labile O-acetyl group remains present on the wall. To liberate O-acetyl
groups from PCW, lyophilized PCW fragments (5-10mg) were incubated in either 400µl
80mM NaOH or pH 6.8 PBS (negative control) for 3 hours at 30°C. After incubation
NaOH was neutralized with an appropriate amount of H2SO4. Following centrifugation
for 10 minutes at 13,000 xg the supernatant was harvested to determine the degree of Oacetylation, which was analyzed using the K-ACET Acetic Acid Analysis Kit
(Megazyme Inc.). Addition of reagents was carried out according to kit protocol. Oacetyl groups were quantified against a standard curve constructed using several
concentrations of acetic acid standard provided in the kit (0.1 mg/mL), and presented as
nano-moles of acetic acid per mg of dry PCW.
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Quantification of Released Lipoteichoic Acid
In order to quantify the amount of LTA released due to exposure to β-lactams,
bacterial supernatants were analyzed via ELISA as described by Van Langevelde et al.
(16) with some modification. An LTA standard curve was produced using purified S.
aureus LTA (Sigma-Aldrich) in concentrations ranging from 0-500 ng. Bacterial
supernatants were incubated undiluted and diluted 10x alongside LTA standard
concentrations with an anti-mouse gram-positive LTA monoclonal antibody (Thermo
Fisher) overnight at 4°C. Following washing the plate was blocked for one hour using a
1:1 mixture of pH 7.2 PBS and low-fat soy milk (28). Detection was facilitated by
observation of OD410 upon the addition of 1-step ABTS (Thermo Scientific) to a goat-αmouse IgG-peroxidase conjugate (Thermo Scientific).
Freeze/Thaw Extraction and Zymographic Analysis of Peptidoglycan Hydrolases
Peptidoglycan hydrolases were extracted from the cellular surface of D592/712
strains grown in the presence or absence of 20 µg/ml NAF by the freeze/thaw method and
analyzed using a zymographic method essentially as described by Koehl et al. (29):
After growing to an OD600 of approximately 0.4, 100ml of culture was harvested at
13,000 xg at 4°C then washed once with cold water and once with 0.01 M phosphate
buffer (pH 7.0) before being resuspended in 1 ml of buffer. The suspension was then
subjected to three freeze/thaw cycles, each cycle consisting of incubation for 1 hour at 80°C followed by 10 minutes at 37°C. Following three cycles the suspension was
centrifuged at 13,000 xg at 4°C for 10 minutes, and the supernatant saved as the
freeze/thaw autolysin extract. 10 µl extracted protein was electrophoresed in a 10% SDS
gel containing 0.2% wt/vol Micrococcus luteus cells. Following electrophoresis the gel
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was incubated overnight in renaturation buffer containing 25 mM Tris-HCl (pH 8.0) and
1% Triton X-100. After renaturation the gel was stained with 1% methylene blue in
0.01% KOH, and destained with dH2O. Peptidoglycan hydrolases (autolysins) are
visualized as clear bands in the gel.
Autolysin Localization Assay
Following freeze/thaw autolysin extraction the protein concentration of extracts
was determined by Bradford assay. Equivalent concentrations of protein extracts were
added to cuvettes containing Micrococcus luteus cells suspended to OD600 = 0.5-0.6, and
the optical density monitored for three hours. Data are presented as a percentage of initial
OD600.
Mode of Killing
Mode of killing experiments were performed essentially according to Cotroneo et
al. (17). Cells were grown to mid-log phase in the presence and absence of 20 µg/ml
NAF and then exposed to 10 µg/ml DAP. Cell viability was quantified as CFU/ml
calculated via broth serial dilution and plating on TSA plates. Alongside cell viability
tests the OD600 of the culture was monitored; a decrease in cell viability without
significant decrease in OD600 implies the killing of cells without lysis, while a decrease in
OD600 implies lysis. The antibiotic concentrations utilized here were derived from Dhand
et al. (4), where a treatment of 20µg/ml NAF and 10µg/ml DAP provided the most
effective bactericidal action.
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CHAPTER III
RESULTS
Growth in the Presence of Nafcillin Increases Whole Cell and CCW Autolysis Rates
Both whole cell and crude cell wall preparations from cells grown in the presence
of nafcillin autolyse at a faster rate (Fig. 1, 2). While unexposed CCW preparations fail
to autolyze almost entirely, losing only about 10% of the initial OD, CCW of exposed
cells clear to approximately 50% and 35% in D712 and D592 respectively.

Figure 1. Triton X-100 Stimulated Whole Cell Autolysis
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Triton X-100 stimulated whole cell autolysis in S. aureus strains D592 and D712
unexposed or exposed to 20μg/ml NAF represented as % decrease of optical density over
4 hours. Significance was determined by K-S test of NAF treated vs. NAF untreated
strains, in each case D > Dα
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Figure 2. Crude Cell Wall Autolysis
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Crude cell wall autolysis of S. aureus strains D592 and D712 unexposed or exposed to
20μg/ml NAF represented as percent decrease of OD over 4 hours. Significance was
determined by K-S test of NAF treated vs. NAF untreated strains, in each case D > Dα

Growth in the Presence of NAF Sensitizes PCW to Lytic Enzymes
Treatment with β-lactam antibiotics is likely to affect the composition of the
overall cell wall with respect to cross-linking or peptidoglycan chain length. To evaluate
cell wall integrity crude cell wall preparations were further purified by boiling in 2% SDS
and incubation with proteinase K. Similar to whole cell and CCW autolysis studies,
NAF+ purified cell wall preparations are much more susceptible to degradation by lytic
enzymes (lysozyme and lysostaphin) than untreated preparations (Fig. 3, 4).
Interestingly, untreated D712 displays slight lysostaphin resistance (Fig. 4); however, this
resistance was negated after growth in NAF.
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Figure 3. Purified Cell Wall Lysis with Lysozyme
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Purified cell wall lysis with lysozyme (100μg/ml) in S. aureus strains D592 and D712
unexposed or exposed to 20μg/ml NAF. Data represented as percent decrease in initial
OD. Significance was determined by K-S test of NAF treated vs. NAF untreated strains,
in each case D > Dα
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Figure 4. Purified Cell Wall Lysis with Lysostaphin
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Purified cell wall lysis with lysostaphin (5μg/ml) in S. aureus strains D592 and D712
unexposed or exposed to 20μg/ml NAF. Data represented as percent decrease in initial
OD. Significance was determined by K-S test of NAF treated vs. NAF untreated strains,
in each case D > Dα

O-acetylation of Cell Walls is not Significantly Affected by Growth in NAF
O-acetylation has previously been shown to aid in immune system evasion (23).
Estimation of O-acetylation levels was performed using the MegaZyme acetic acid assay
kit as reported elsewhere (30) and the total released acetate is reported. While Oacetylation levels do vary by about 7% between treated and untreated strains of D712 this
trend does not hold true for D592 (Fig. 5). In addition, while high levels of O-acetylation
have been demonstrated in previous studies (23) to contribute to lysozyme resistance, we
did not consider this relatively small difference a to be a significant source of increased
lysozyme resistance, and did not pursue it further.
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Figure 5. Cell Wall O-acetylation
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Cell Wall O-acetylation of S. aureus strains D592 and D712 grown with or without NAF
(20µg/ml). Samples marked “(-)” are negative controls incubated in pH 6.8 PBS to
assure no release of O-acetyl groups.

LTA Release is Increased in Response to NAF Treatment
To determine and quantify the amount of LTA released into culture medium
ELISA was performed. Cells grown in sub-MIC concentrations of nafcillin exhibited an
increase in the amount of LTA released into culture medium by an average of
approximately 120 ng/ml (Fig. 6), interestingly, significance was detected in strain D712
via a paired sample t-test but not strain D592.
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Figure 6. Quantified Release of Lipoteichoic Acid
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LTA release as a result of NAF exposure. Growth in NAF results in an approximate 30%
increase in LTA release. Significance was detected in strain D712 upon growth in
nafcillin (p < 0.05) while no significance was found for D592.

Growth in NAF Alters Atl Processing
S. aureus strains grown in nafcillin were hypothesized to undergo a delocalization
of the major cellular autolysin Atl. A method was developed to infer the location of Atl
in the cell wall during exponential phase. If increased rates of autolysis upon beta lactam
treatment are due to delocalized surface autolysins, and not an increased or decreased
amount of enzyme, there should be no significant difference in autolysis rates between
treatments within the same strain. Cells were harvested in exponential phase (OD600 0.40.5) and subjected to freeze/thaw extraction. To verify lytic activity of extracts each
extract was subjected to zymographic analysis (Fig 7). 10 μl of freeze/thaw extract from
each treatment was electrophoresed on a polyacrylamide gel containing 0.2% lyophilized
Micrococcus luteus cells and clearing of stained cells was observed. Following
20

confirmation of lytic activity the protein concentration of each extract was determined by
Bradford assay (Fig. 8), and suspensions of M. luteus were challenged with equivalent
amounts of protein from each extract. Differences in band intensity observed during
zymographic analysis are due to differences in total protein concentration of extracts.
Differences in protein extracted per strain and treatment may be a result of differences in
extraction efficiency. Both 1 µg (data not shown) and 10 μg (Fig. 9) treatments display
little to no activity in suspension.
Figure 7. Zymographic Analysis

Zymographic analysis for verification of lytic activity of freeze/thaw protein extracts.
Zymogram was prepared pre-Bradford assay to verify activity of extracts. 10 µl of each
extract was added per well; differences in band intensity are due to different overall
protein concentration of extracts.
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Figure 8. Quantification of Extracted Protein
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Protein extracted via freeze/thaw as quantified by Bradford assay.
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D712+NAF

Figure 9. Lysis of M. luteus Cells by 10 µg Extracted Protein
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Lack of lysis of M. luteus cells by 10 μg freeze/thaw protein extract. 10 μg of protein
extract was added to cuvettes containing M. luteus cells at OD600 ~0.6. Data represented
as a percent decrease in initial OD.

NAF+Dap is Lytic in Action and Ineffective against Stationary Phase Cells
NAF and DAP exhibit distinct mechanisms that result in loss of cell viability in
different ways. While NAF induces cell lysis through a weakening of the cell wall, DAP
is able to cause loss of viability without lysis by disrupting cell membrane polarization
affecting protein, DNA, and RNA synthesis. To determine if cells undergoing
NAF+DAP treatment are dying preferentially to one antimicrobial mechanism, its
potency was tested against exponential and early stationary phase cells. Exponential
phase cells exhibited lysis as a result of NAF+DAP treatment as is indicated by the
dramatic decrease in optical density upon addition of DAP (Fig. 9), while those untreated
with DAP continue to grow normally. Stationary phase cells growing in the presence of
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NAF were largely unaffected by DAP, and in some cases continued to grow
(D712+NAF+DAP) (Fig. 10).

Figure 10. Growth Curve of D592 and D712 DAP Added at Exponential phase
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DAP 10 µg/ml added to each culture after first reading OD600 > 0.4 (arrows)
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Figure 11. Growth Curve of D592 and D712 DAP Added at Stationary phase
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CHAPTER IV
DISCUSSION
MRSA infections are a serious but treatable problem. Unfortunately, in the case
of S. aureus resistance is an inevitable outcome. Evolution of resistance phenotypes
leaves practitioners with the necessity of using novel drugs that have extensive
development time and may be cost prohibitive to the patient. An alternative treatment in
cases with particularly stubborn infections is the use of combination therapy.
Daptomycin+Nafcillin is an extremely potent combination with well documented
effectiveness (4). While the potency of this combination has been known for some time,
its mechanism of action has remained unclear. A necessary first step in fully elucidating
the mechanism of this antibacterial combination is knowledge of multiple physiological
markers present in the bacterial cell wall when undergoing beta-lactam therapy to provide
clues for future research.
Here we have examined a number of physiological traits present in DAP-R S.
aureus cells to provide a more complete physiological profile of the DAP-R phenotype in
response to β-lactam treatment. Whole cells and crude cell wall preparations become
much more susceptible to autolysis upon growth in β-lactam containing media,
suggesting an overall weakened cell wall. Cell wall disruption by β-lactams is due to
interruption of the PBPs, and in S. aureus a significant degree of cell wall integrity is
derived from cross-linking. Cross-linking in MRSA has previously been shown to be
decreased due to inhibition of PBP4 (17, 31), a phenomenon exhibited by PBP non26

specific β-lactams such as NAF. The ability of lysostaphin to rapidly lyse PCW from
cells grown in the presence of NAF supports the presence of hypo-crosslinked cell walls.
Lysostaphin targets the pentaglycine cross-bridge of S. aureus to significantly disrupt cell
wall integrity and cause lysis. Interestingly, we detected notable lysostaphin resistance in
strain D712 when grown in the absence of NAF. Lysostaphin resistance is not well
understood, however, lysostaphin resistance A (lyrA) has been determined as a major
factor (32). Interestingly, lyrA does not significantly modify the pentaglycine crossbridge
to produce an un-bindable substrate for lysostaphin (32). Should this phenotype be
pursued in future work, sequencing is first required to examine this strain for any lyrA
mutations, along with other mutations that may be compounding factors such as femAB,
which produces significant alterations in pentaglycine crossbridges (32).
Additionally, PCW from cells grown in NAF exhibited increased susceptibility to
lysozyme. O-acetylation has been implicated as a major effector of lysozyme resistance
in cells with O-acetylated NAM subunits, and while levels of O-acetylation do decrease
slightly upon growth in nafcillin the difference in this case is negligible in the case of
D712 while being almost entirely absent in the case of D592. O-acetyl groups are highly
alkali-labile, and extensive care must be taken to keep all pH conditions under 7.0 when
preparing PCW to ensure the retention of O-acetyl groups. PCW lysis assays were
performed in a pH 7.5 Tris-HCl buffer, which has potential to liberate O-acetyl groups
from PCW samples. Since we see a significant effect of β-lactam treatment on lysozyme
susceptibility under conditions that should remove a main factor in lysozyme resistance
there should be another factor affecting lysozyme’s inability to lyse non-β-lactam treated
PCW. If we wish to explore this phenomenon further, a necessary next step will be to
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extract O-acetyl groups from PCW samples as done when determining O-acetylation
levels and treat these newly O-acetyl group free PCW samples with lysozyme. In
addition, further work should be done to definitively determine O-acetylation levels by
using previously established methods (28).
An additional source of disrupted cell wall integrity could lie in inhibition of
PBP1. Recent work suggests that β-lactams that selectively bind PBP1 potentiate DAP to
a greater extent than those that specifically target other PBPs (6). PBP1 of S. aureus is
homologous to PBP3 of E. coli, which interacts with important cell division machinery
(6), and recent studies suggest that interruption of PBP1 activity is implicated in
construction of aberrant cell walls (33). NAF is a nonselective β-lactam and exhibits a
degree of binding to all PBPs (33), thus, in addition to inactivation of PBP2. Repetition
of these experiments using β-lactams specific for certain PBPs may help clarify this
phenomenon.
We observed a significant increase in the release of LTA into culture medium
from cells undergoing growth in β-lactam containing media. Teichoic acids play
numerous roles in the cell and their full function is not yet understood, however, previous
work has determined that, while the absence of either LTA or WTA is non-lethal, the cell
cannot survive the absence of both (27). LTA and WTA are implicated in many cellular
processes, and an important modification for that function is the D-alanylation of LTA
(24). Enhanced DAP binding has already been observed upon β-lactam treatment, and
the exact mechanism by which this happens has yet to be determined (4). One suggestion
for increased DAP binding in the presence of nafcillin is that the release of D-alanyl LTA
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results in a less positive membrane environment that lessens the impact of lysylphosphatidylglycerol in a charge repulsion mechanism (4).
We aimed to examine the localization Atl as a possible source of increased whole
cell and crude cell wall autolysis. In addition to autolysis assays, we extracted Atl from
cell walls as bulk protein extract by the freeze/thaw method. When M. luteus cells were
exposed to equivalent amounts of cell wall protein extracts we hoped to observe similar
lysis rates, implying that the fraction of Atl in any given treatment is similar, and that the
increased rates of autolysis are not due to an increase in Atl number or activity, but rather
could be due to the location of the enzyme. However, we did not observe any degree of
lysis in either 1 µg or 10 µg treatments, which may be due to the amount of protein used
in the assay. While cells also fail to lyse when exposed to 10 µg of extracted protein,
there are slightly more pronounced differences. This particular experiment needs to be
repeated with higher concentrations of extracted protein to fully determine if there is any
significant difference in cell wall protein extracts of these strains when treated with NAF.
Atl is a tightly regulated enzyme due to its ability to degrade peptidoglycan, and it
is likely that delocalized and unregulated Atl activity could cause significant weakening
of the cell wall. D-alanyl WTA has been proposed as a method of Atl sequestration. As
reported earlier, previous work has determined that D-alanine on WTA are derived from
LTA. Earlier studies have suggested that the ease with which D-alanine moves
throughout the envelope could provide an essential environment for proteins that require
specific ionic conditions, some of which are autolysins (24). If D-alanine plays a
significant role in autolysin sequestration, and β-lactam treatment results in the release of
LTA from the cell membrane, then upon β-lactam treatment there is likely to be little D-
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alanine present on WTA and thus, delocalized Atl. Assuming delocalization of Atl upon
β-lactam treatment suggests a range of other effects. Delocalized Atl in this case is likely
not enough to cause cell death on its own, however, it is likely to weaken the cell wall.
Atl delocalization as a result of the loss of D-alanyl LTA could cause holes in the wall
that are big enough to allow the relatively large DAP molecule (~1.6 kDa) to better
penetrate the wall and find its target. While these experiments suggest a delocalization of
Atl they are far from final. Construction of a fluorescent Atl mutant, quantification of Atl
transcription by qPCR, or other methods to identify the exact location of Atl on the cell
wall during beta-lactam therapy are necessary steps to definitively demonstrate this
phenomenon. The effects of β-lactam treatment on cell wall thickness and cross-linking
described here could contribute, along with delocalization of Atl to an enhanced ability of
DAP to penetrate the cell wall and reach its binding target at the cell membrane.
DAP has been previously shown to be able to kill without lysis, demonstrating an ability
to kill stationary phase cells (17). We aimed to determine the main mode of killing by
examining culture optical density and corresponding CFU/ml. Exponentially growing
cells show a clear decrease in OD600 and are thus overwhelmingly lysing. Stationary
phase cells challenged with NAF+DAP do not appear to exhibit lysis, and, in the case of
D712, continue growing. Since stationary-phase cells are not actively growing and
dividing the effect of NAF on cell viability will be insignificant even in stationary-phase
NAF-susceptible cells. What remains to be determined, however, is if β-lactam-mediated
increased DAP binding persists in stationary-phase cells, and whether DAP binding under
those conditions is sufficient to cause cell death. Future studies may seek to perform
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experiments similar to those done in previous work (4) on stationary phase cells exposed
to this drug combination.
Future Directions
Given the complex nature of DAP resistance it is unlikely for the phenotype to be
completely understood, however, the work done for this thesis could support several
areas of future work. Avenues for future research could involve examination of the
resistance of PCW to lysozyme in the apparent absence of O-acetyl groups. As
mentioned previously, fully removing O-acetyl groups from PCW preparations and
treating with lysozyme should provide some clarity. In addition to examining PCW
lysozyme resistance, it may be more intriguing to determine the cause of lysostaphin
resistance in untreated D712 since this phenotype is unexpected, relatively unresearched,
and especially interesting due to the reversion to a susceptible state upon β-lactam
treatment. Cell wall thickness/crosslinking should be examined pre and post-β-lactam
treatment to determine if any significant decrease is present, and, whether that decrease
plays a role in more significant DAP binding. Additionally, it is still unclear if
stationary-phase cells are sensitive to NAF+DAP therapy. Though this is unlikely,
experiments similar to those performed by Dhand et. al (4) could provide clarity.
The inferential process used here to determine Atl localization is imperfect, and
definitive confirmation of delocalized Atl requires additional techniques. One way to
support this work is through the use of qPCR to determine if the Atl gene is up/down
regulated upon beta-lactam treatment. Similar levels of transcription among strains
growing exposed and unexposed to NAF would support the data presented here. In
addition to qPCR, construction of a fluorescent protein labeled Atl strain for direct
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microscopic visualization is essential, however, while this process is possible, it may be
prohibitively cost or time-consuming. What also may be possible is to design an
immunofluorescent system using monoclonal antibodies specific to the amidase and
glucosaminadase domains of Atl. Recent work has proposed the creation and use of
monoclonal antibodies to the glucosaminidase domain to disrupt MRSA cell growth
during osteomyelitis (34). Visualization of Atl during beta-lactam treatment is a
necessary next step in elucidation of this mechanism.
Conclusions
Daptomycin resistance remains a complex problem with several genes implicated
and significant differences among those strains deriving resistance in vitro versus those in
vivo. Despite this complexity here we have provided clarification of the physiological
profile of an in vivo-derived DAP-R strain and its isogenic DAP-S precursor undergoing
beta-lactam therapy. Specifically, we have found that Growth of DAP-S and DAP-R
MRSA in the presence of the nafcillin increases whole cell and crude cell wall (CCW)
autolysis, and Growth in NAF increases susceptibility to lysozyme and lysostaphin.
These effects are likely due to an overall weaker cell wall. Interestingly, increases in
PCW susceptibility to lysozyme appear to be independent of the levels of O-acetylation.
In addition, we found apparent alteration in Atl processing, and observed NAF+DAP to
kill exponentially growing cells via lysis and have no apparent effect on stationary phase
cells. Future work may include direct visualization of Atl, more in-depth examination of
cell wall thickness/crosslinking, and exploration of the lysostaphin resistance exhibited
by strain D712.
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APPENDIX A
SUPPLEMENTAL FIGURES
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Figure S1. MegaZyme Acetic Acid Kit Acetic Acid Standard Curve
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Figure S2. BSA Standard Curve for Protein Concentration Determination (Bradford
assay)
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Figure S3. LTA ELISA Standard Curve
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